Economic evaluation supports prophylactic naldemedine for opioid-induced constipation in cancer palliative care
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Economic evaluation supports prophylactic naldemedine for opioid-induced constipation in cancer palliative care
FDA approves isatuximab-irfc for subcutaneous injection for multiple myeloma indications
FDA approves pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph each with enfortumab vedotin-ejfv for muscle invasive bladder cancer
Young women diagnosed with breast cancer within three years of childbirth may face more aggressive disease
Do breast cancer and irregular heartbeat have common risk factors and rates?
American Cancer Society reports latest global cancer statistics; Cancer cases approach 21 million worldwide, with burden projected to surge 67% by 2050
Scientists uncover why some patients with rare leukaemia may not benefit from approved targeted therapy
Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients with B-cell ALL
Study paves the way for a new drug against metastatic prostate cancer
Study shows that obesity promotes lung cancer by suppressing immune response
Common thyroid hormone may help prevent brain tumour relapse in children, says study
Two in five women with ovarian cancer diagnosed only after emergency admission